-
Color Receives Genetic Counseling Grant for All of Us
Aug 21, 2019, 11:20 AM by Michael CroftBio-IT World | The All of Us research program has awarded $4.6 million in initial funding to Color, a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource. Through this funding, Color’s network of genetic counselors will help participants understand what the genomic testing results mean for their health and their families.Full story -
Signant Health Appoints Todd Everhart as Clinical Vice President to Accelerate Intelligent eCOA and Predictive Data Analytics in Medical Clinical Research
Aug 20, 2019, 10:27 AM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Aug 20, 2019 - Signant Health, formerly CRF Health and Bracket, has appointed Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as Clinical Vice President, Internal Medicine, reporting to the Chief Medical Officer, DrFull story -
Creative Diagnostics Introduces New Lyophilized Exosomes for Research
Aug 20, 2019, 04:18 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 20, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces that it has developed lyophilized exosomes for global researchers, which are isolated from different biological sources including human biofluids of certified healthy donors (plasma, serum, urine, saliva) and different cell culture supernatantFull story -
Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma
Aug 19, 2019, 14:56 PM by Michael CroftPITTSBURGH, PA - Aug 19, 2019 - Knopp Biosciences LLC today announced the start of Phase 2 dose-ranging clinical trial in moderate-to-severe eosinophilic asthmaFull story -
Strata Oncology Announces Partnerships with Five Additional Health Systems
Aug 17, 2019, 14:08 PM by Michael CroftBELFORD, NJ, US - Aug 16, 2019 - ANN ARBOR, Mich. -- Strata Oncology, a precision oncology company enabling molecular indications for cancer therapeutics, today announced Baptist Health (KY), Lehigh Valley Health Network (PA), Marshfield Clinic (WI), MultiCare Health System (WA), and Prisma Health (SC) have joined the Strata Precision Oncology Network (the "Network")Full story -
U.K. Firm Creates Operating System To Handle Massive Genomic Patient Data Sets
Aug 16, 2019, 17:38 PM by Michael CroftForbes | We're making work digital on every desktop, we're empowering digital sensors in the Internet of Things (IoT) on every street corner, we're building smart digital AI-powered IT systems with machine learning and decision-making abilities to automate our lives… and we're digitizing ourselves as well.Full story -
Creative Enzymes Has Upgraded Four Enzymes Services for Bio-researchers
Aug 16, 2019, 04:47 AM by Michael CroftNEW YORK, NY - Aug 16, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has upgraded four enzymes related services, such as enzyme expression and purification, and enzyme engineering services for researchers working in the life science fieldFull story -
20% Enrollment For All of Us Program, Challenges Remain
Aug 15, 2019, 12:55 PM by Michael CroftBio-IT World | The All of Us research program announced updates today in a special report published in the New England Journal of Medicine. As of July 2019, the All of Us program has enrolled more than 175,000 core participants (those who contributed personal information, biospecimens, and physical measurements and who agreed to share EHR data) and more than 230,000 total participants; an additional 40,000 participants have registered on the website, the authors report. “More than 80% of these participants are from groups that have been historically underrepresented in biomedical research,” the authors observe.Full story -
New BioIVT Research Examines Potential Link Between HIV Integrase Inhibitor Drugs and Neural Tube Defects During Pregnancy
Aug 15, 2019, 08:28 AM by Michael CroftWESTBURY, NY - Aug 15, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that researchers in its Transporter Sciences Group have co-authored a peer-reviewed DMD paper, which investigates the inhibitory effects of a class of HIV drugs known as integrase inhibitors on folate transporter pathwaysFull story -
Size really does matter when purchasing equipment for laboratories
Aug 14, 2019, 12:15 PM by Michael CroftGUILDFORD, UNITED KINGDOM - Aug 14, 2019 - Laboratories are nearly always short of space which means bulky or very heavy equipment cant be accommodated or has to be housed away from the laboratoryFull story -
Tackling the Affinity Gap at Amgen
Aug 14, 2019, 11:55 AM by Michael CroftBio-IT World At Amgen, Agnieszka Kielczewska had a problem. The AMGN12 antibody, derived from an in vivo immunization of the XenoMouse, demonstrated single digit pM affinity to the human orthologue of the target protein, but a 200-fold weaker binding to the monkey orthologue. In order to conduct toxicology studies in non-human primate species, Amgen needed that affinity difference to be closer to 10-fold.Full story -
Creative Biolabs Has Updated Its Product Type for Therapeutic Antibodies
Aug 14, 2019, 02:45 AM by Michael CroftSHIRLEY, NY - Aug 13, 2019 - August 13, 2019, as a leading supplier and manufacturer in antibody field, Creative Biolabs recently has updated its new product types for therapeutic antibody, which has at least three types of mechanismsFull story -
Nvidia just made it easier to build smarter chatbots and slicker fake news
Aug 13, 2019, 10:42 AM by Michael CroftMIT Technology Review | Chipmaker Nvidia is betting that AI's language skills will advance rapidly-it's releasing a powerful tool for putting together chatty programs.Full story -
Biobanking Is Changing The World
Aug 13, 2019, 10:29 AM by Michael CroftForbes | With the evolution of biobanks rapidly enabling the creation of massive collections of biological material and associated information, how are these collected terabytes of data transforming nations?Full story -
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Aug 13, 2019, 05:01 AM by Michael CroftRESEARCH TRIANGLE PARK, NC - Aug 13, 2019 - AskBio, the worlds foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expressionFull story -
National Genomic Data Initiatives: A Worldwide Update
Aug 12, 2019, 09:55 AM by Michael CroftBio-IT World | The global movement toward the application of genomics to medical practice is exciting because it is essentially "precision medicine come real," says Ewan Birney, chair of the Global Alliance for Genomics and Health (GA4GH). But which countries are involved? And what progress has been made so far? Bio-IT World’s overview offers an update on currently active national government-funded genomic-medicine initiatives, grouped by area of emphasis.Full story -
Signant Health Launches Partner Program to Team with Clinical Research Organizations (CROs) Committed to Improving Clinical Trials with Patient-Centric Technology
Aug 12, 2019, 09:19 AM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Aug 12, 2019 - Signant Health (signanthealth.com), a leading provider of technology for clinical research, today launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality SolutionsFull story -
Creative Enzymes Has Launched several enzymes services for Bio-researchers
Aug 12, 2019, 05:52 AM by Michael CroftNEW YORK, NY - Aug 12, 2019 - Creative Enzymes Has Launched several enzymes services for Bio-researchers SHIRLEY, NY - Aug, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has launched five enzymes related services, such as biocatalysis service, enzyme engineering, enzyme modification, enzyme conjugation, and enzyme formulation for researchers working in the life science fieldFull story -
Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing
Aug 12, 2019, 04:19 AM by Michael CroftSHIRLEY, NY - Aug 12, 2019 - It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracyFull story -
Bacteria On Tumors Influences Immune Response, Survival Of Patients With Pancreatic Cancer
Aug 9, 2019, 09:05 AM by Michael CroftFull storyBio-IT World News Brief | A team led by researchers from The University of Texas MD Anderson Cancer Center reports that a key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response.